3 studies found for:    cp18
Show Display Options
Rank Status Study
1 Terminated Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects
Condition: Breast Cancer
Intervention: Radiation: [F18]CP-18 Injection
2 Withdrawn 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Conditions: Ovarian Neoplasms;   Ovarian Cancer;   Fallopian Tube Neoplasms;   Fallopian Tube Cancer
Interventions: Drug: [18F]-CP18;   Procedure: PET/ CT
3 Completed
Has Results
A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: IMC-A12;   Drug: Mitoxantrone;   Drug: Prednisone;   Biological: IMC-1121B (ramucirumab)

Indicates status has not been verified in more than two years